Marketplace / Healthtech / Seed
EyeMacular Regeneration, Inc.
“Developing specialized surgical instruments and platform technologies for end-stage macular disease.”
Open round — EyeMacular Regeneration, Inc. is raising $2.0M for its Seed
The founder is taking investor conversations now, and on PitchSpark you reach them directly — no warm intro, no gatekeeper. Create a free investor account to see the financials and the deck, then message the founder in one click.

Overview
EyeMacular Regeneration is a medical technology company developing specialized surgical instruments and platform technologies for patients with end-stage macular disease. The company focuses on a novel field called Incisional Choroidal Surgery (ICS) to address severe vision impairments.
Traction
as reported by the founderPatients with end-stage age-related macular degeneration (AMD) often exhaust all existing treatment options, leaving them with limited solutions for their condition.
The company has developed innovative, practical surgical instruments and platform technologies designed to integrate seamlessly into existing vitreoretinal surgical workflows.
Company updates
No updates posted yet.
Follow this company
Get an email when EyeMacular Regeneration, Inc. posts an update. No account needed — one click to unsubscribe.
Achievements
EyeMacular Regeneration, Inc. — raising $2.0M
Deck · financials · founder contact